TY  - CHAP
M1  - Book, Section
TI  - Treatment of Obesity: The Impact of Bariatric Surgery
A1  - Robinson, Malcolm K.
A1  - Greenberger, Norton J.
A2  - Greenberger, Norton J.
A2  - Blumberg, Richard S.
A2  - Burakoff, Robert
PY  - 2016
T2  - CURRENT Diagnosis & Treatment: Gastroenterology, Hepatology, & Endoscopy, 3e
AB  - ESSENTIAL  CONCEPTSBody  mass  index  (BMI)  >25  is  considered  overweight;  >30,  grade  I  obesity;  >35,  grade  II  obesity;  >40,  grade  III  obesity;  and  >50,  “super  obesity.”Using  these  criteria,  two-thirds  of  Americans  are  overweight  or  obese.Diet,  pharmacotherapy,  and  behavior  modification  are  the  available  nonsurgical  treatment  options  and  are  of  limited  efficacy,  with  durable  weight  loss  rarely  exceeding  10  kg.Patients  with  a  BMI  >35  can  be  considered  for  bariatric  surgery  if  they  have  severe  weight-related  comorbid  conditions  (eg,  diabetes,  hypertension,  disabling  arthritis,  or  sleep  apnea).Patients  with  a  BMI  >40  may  be  appropriate  surgical  candidates,  with  or  without  weight-related  comorbid  conditions.Two  long-term  studies  of  the  efficacy  of  bariatric  surgery  noted  a  29–40%  reduction  in  all  causes  of  death,  with  decreased  mortality  from  coronary  artery  disease,  stroke,  diabetes,  and  cancer.Several  studies  have  documented  the  profound  effects  that  bariatric  surgical  procedures  have  in  the  treatment  of  diabetes.  The  American  Diabetes  Association  and  the  International  Federation  for  Diabetes  now  recommend  that  bariatric  surgery  be  considered  for  morbidly  obese  individuals  who  have  poorly  controlled  type  2  diabetes  with  medical  therapy.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/25
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1119987482
ER  -